Innate immune reactivity of the ileum - Liver axis in nonalcoholic steatohepatitis

Digestive Diseases and Sciences

Volumn 57, Issue 5, 2012, Pages 1144-1151

  Tsujimoto, Tatsuhiro ^a   Kitazawa, Toshiyuki ^a   Fukui, Hiroshi ^a   Kawaratani, Hideto ^a   Uemura, Masahito ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ileum; Innate immunity; Liver; Nonalcoholic steatohepatitis; TLR4

Indexed keywords

ALANINE AMINOTRANSFERASE; CD14 ANTIGEN; GAMMA INTERFERON; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ILEUM; IMMUNOREACTIVITY; INNATE IMMUNITY; KUPFFER CELL; LIVER HISTOLOGY; MACROPHAGE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ALANINE TRANSAMINASE; ANIMALS; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; FATTY LIVER; GRAM-NEGATIVE BACTERIA; ILEUM; IMMUNITY, INNATE; KUPFFER CELLS; LIVER; MALE; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTORS;

EID: 84864070013     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2073-z     Document Type: Article

References (21)

1. Day CP, James OF. Steatohepatitis: a tale of two ''hits''? Gastroenterology. 1998;114:842-845.
2. Tsujimoto T, Kawaratani H, Kitazawa T, et al. Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model. World J Gastroenterol. 2008;14:6036-6043.
3. Tsujimoto T, Kuriyama S, Yamazaki M, et al. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol. 2001;18:41-47.
4. Tsujimoto T, Kawaratani H, Kitazawa T, et al. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World J Gastroenterol. 2009;15: 5533-5540.
5. Tomita K, Tamiya G, Ando S, et al. Tumour necrosis factor alpha signaling through activation of Kupffer cells plays an essential role in liver fibrosis of nonalcoholic steatohepatitis in mice. Gut. 2006;55:415-424.
6. Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver disease. Gut. 2009;58:704-720.
7. Nakae D, Mizumoto Y, Yoshiji H, et al. Different roles of 8-hydroxyguanine formation and 2-thiobarbituric acid-reacting substance generation in the early phase of liver carcinogenesis induced by a choline-deficient, L-amino acid-defined diet in rats. Jpn J Cancer Res. 1994;85:499-505.
8. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413-1419.
9. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-2474.
10. Seglen PO. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res. 1973;82:391-398.
11. Olynyk JK, Clarke SL. Isolation and primary culture of rat Kupffer cells. J Gastroenterol Hepatol. 1998;13:842-845.
12. Kubo S, Rodriguez T Jr, Roh MS, et al. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin. Hepatology. 1994;19: 1044-1049.
13. Fukui H, Brauner B, Bode JC, et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: revaluation with an improved chromogenic assay. J Hepatol. 1991;12:162-169.
14. Kawaratani H, Tsujimoto T, Kitazawa T, et al. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model. J Gastroenterol Hepatol. 2011;26:775-783.
15. Kitazawa T, Tsujimoto T, Kawaratani H, et al. Therapeutic approach to regulate innate immune response by toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. J Gastroenterol Hepatol. 2009;24:1089-1094.
16. Kawaratani H, Tsujimoto T, Kitazawa T, et al. Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-aciddefined diet. World J Gastroenterol. 2008;14:6655-6661.
17. Wagnerberger S, Spruss A, Kanuri G, et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr. 2011;10:1-12.
18. Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16: 4652-4660.
19. Kitazawa T, Tsujimoto T, Kawaratani H, et al. Expression of tolllike receptor 4 in various organs in rats with D-galactosamineinduced acute hepatic failure. J Gastroenterol Hepatol. 2008;23:e494-e498.
20. Abe M, Tokita D, Raimondi G, et al. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol. 2006;36:2483-2493.
21. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol. 2004;4:499-511.